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As of 2018 it is estimated that 1/3 of men and women will develop cancer 
in their lifetime (1). There are numerous potential reasons for the growing incidence 
of cancer. Undeniably increased lifespan compared to our ancestors is a major 
factor as 87% of people diagnosed with cancer are over 50 years old (1). However, 
lifestyle also plays an important role in the development and progression of cancer 
(11). In recent years there has been a decline in cancer mortality due to earlier 
detection, better treatments and decreasing rates of smoking (1). Despite this, 
increasing survival rates have led to an increased incidence of secondary cancers 
developing (2). Additionally, stage IV cancer 5-year survival rates remain low. 
Therefore, new ideas are needed in cancer research. One promising area of research 
is evolutionary medicine; by looking at how evolutionary principles influence the 
growth and development of cancer, researchers may be able to develop new 
strategies for preventing and treating cancer.  
Researchers have hypothesized that cancer cell development as well as the 
clonal proliferation of cancerous cells follows Darwinian mechanics (6-7). Cellular 
stress causes mutations which in turn creates variation. Unfavorable mutations, 
which decrease cellular fitness, are selected against and favorable mutations, which 
increase cellular fitness, are selected for. Fitness is determined by a cell’s 
phenotype not its genotype. Due to shared selection pressures, cancerous cells 
converge on similar phenotypic traits; these traits are known as the hallmarks of 
cancer (12).  Cells with increased fitness proliferate and create clones which can 
further undergo mutations, which in turn can further enhance their fitness. Stem 
cells have been hypothesized to be the unit of selection; these cells express 
increased plasticity, have unlimited replicative potential, and survive long enough 
to accrue the mutations necessary to become cancerous (17). 
It has also been hypothesized that the tumor microenvironment stresses and 
applies selective pressure on cells (13). The tumor microenvironment consists of all 
the cells, vessels, nutrients and soluble factors, such as cytokines, that are found 
surrounding and interacting with the tumor (16).  Additionally, cells are not passive 
but can interact with and engineer the environment around them (13-15). Cells can 
also interact with one another, and can compete and cooperate for resources (5,18). 
This leads to tumor heterogeneity as different subclones occupy different niches. 
Increased tumor heterogeneity is associated with more aggressive tumors and may 
increase the metastatic potential of a tumor (5,18).  
It has been proposed that cellular stress promotes cellular heterogeneity (22). 
Increased heterogeneity leads to cellular evolution, which may in the end lead to 
the development of cancer (22). Therefore, anything that leads to cellular stress, such 
as an inflammatory microenvironment, may lead to the development of cancer. The 
goal of cancer prevention strategies should be to decrease overall cellular stress. 
However, not all stress is deleterious to our health. Intermittent exposure to stress, 
such as exercise, has beneficial effects (73). This is known as eustress. When stress 
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begins to negatively affect our body it is known as distress. Many stressors can be 
both beneficial or harmful depending on the dose and duration of exposure (74-75). 
One major source of stress comes from our modern lifestyles. There is discordance 
between how we evolved to live and how we currently live which causes a host of 
issues. This is known as evolutionary mismatch theory (70-71).  
Cancer is not a modern disease as there is robust evidence of cancer in the 
archeological record (24). However, it appears that cancer rates in the past century 
have steadily increased (25). Although there are limited data on cancer rates among 
hunter gatherer populations, what data there are suggest their rates of cancer, as 
well as other chronic diseases, were significantly lower compared to modern 
humans (26-27). Therefore, it is prudent to look at the lifestyles of our ancestors to 
gain insight into how best to avoid lifestyles that may promote the development of 
cancer as well as chronic illnesses.  
Some mismatches are well known causes of cancer, and society has already 
begun shifting away from these behaviors. For example, it is well established that 
excess UV exposure causes skin cancer (28), smoking causes lung cancer (29), excess 
salted food consumption causes gastric cancer (30), and chronic infections can lead 
to a host of different cancers (31). However, there are many other behaviors that have 
been hypothesized to be mismatches and require further research and investigation. 
The reason they are less well known is because they may work through multiple 
mechanisms and may not directly cause cancer. Instead they may increase systemic 
stress driving cellular mutation that may lead to cancer as discussed above. Just this 
year it was found that a lack of exposure to infectious stimuli in infancy can pre-
dispose children to develop acute lymphoblastic leukemia (32). However, inherited 
mutations, diet and chance also play a role (32).   
Our modern diets may play a role in the development of cancer; however, 
the extent of that role is currently unknown. Depending on the type of cancer, intake 
of all macronutrients has been associated with the development of cancer. When 
comparing modern diets to those of hunter-gatherer populations, the quality of our 
diets is significantly worse. We consume food that contains less micronutrients, 
less fiber, more toxins, is more processed, and is more inflammatory (33-34). We also 
consume more calories and our rates of obesity are the highest they have ever been. 
Increased body fat increases the risk of developing cancer (35) while also increasing 
inflammation (36-37) and suppressing the immune system (38). Our diet as well as 
obesity also has a significant impact on our microbiome (39). Industrialized humans 
have the lowest abundance and diversity of gastrointestinal microorganisms across 
all primate species (40). Altered gastrointestinal microbiomes can result in increased 
inflammation (41-42), altered immunosurveillance (44), altered metabolism (45), and 
directly cause genomic instability and increased cellular proliferation (43).  While 
isolated on their own each of these factors may not lead to the development of 
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cancer; together, they increase cellular stress which in turn may lead to the 
development of cancer.  
A branch of evolutionary theory is life history theory.  Life history theory 
studies how natural selection has shaped organisms to take resources from their 
environment and convert them into offspring (46-48). Organisms must balance 
aspects of fitness such as somatic development, maintenance and reproduction (46-
48). These aspects of fitness are known as life-history traits. If resources are 
allocated to one area, they are unavailable for use in another area and this is known 
as life-history tradeoffs (46-48). These tradeoffs may influence the risk of developing 
cancer. For example, taller males tend to be more reproductively successful; 
however, they also have a higher risk of developing cancer (69). 
There are significant differences between the reproductive patterns of 
female hunter gatherers and females living in industrialized societies (49-50). These 
differences may explain the increasing rates of breast cancer among industrialized 
women compared with hunter gatherer populations (49). Females in industrialized 
societies, in general, undergo menarche at an earlier age, have children at a later 
age, have fewer children, breast feed for a shorter duration and overall have more 
menstrual cycles (49-50). Furthermore, women in industrialized societies have higher 
rates of obesity (11), have access to hormone replacement therapy (51), birth control 
(52), and are exposed to numerous xenoestrogens in the environment (53-54).  These 
factors can influence circulating estrogen levels which in turn may influence the 
development of breast cancer. A similar pattern can be seen in rates of prostate 
cancer between men from industrialized societies versus men from non-
industrialized societies. Men living in industrialized countries have a 6-10-fold 
higher incidence of prostate cancer (55-56). When men from non-industrialized 
countries migrate to an industrialized country their risk of prostate cancer, over 
time, increases to levels similar to those of the industrialized population (55-56). This 
may be due to multiple factors, but it is believed that access to more calories leads 
to increased testosterone levels which may influence prostate cancer development 
and growth (55-56). In both these instances, moving away from a traditional hunter 
gatherer lifestyle may influence the risk of developing cancer by affecting hormone 
levels. 
Some mismatches that are often overlooked when it comes to their role in 
the development of cancer are stress, sleep, and exposure to environmental 
toxicants. It has been found that stressors early in life (57-58) as well as in adulthood 
(59) may predispose individuals to developing cancer. Undoubtedly our ancestors 
were exposed to stress; however, the persistent stress responses induced by our 
modern environments have multiple negative effects on our health. Stress has been 
found to inhibit the immune system (60-61), increase inflammation (62), alter our HPA 
axis (63) and change our DNA methylation patterns (64). Similarly, modern sleep 
patterns differ significantly from our ancestors which also may play a role in the 
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development of cancer (65-66). Lastly, modern humans are exposed to countless 
environmental toxicants compared to our hunter gatherer ancestors. The extent that 
these chemicals affect our bodies and the mechanisms by which they do so are 
currently unknown; however, it is thought that they may directly alter the tumor 
microenvironment (67-68). It is difficult to ascribe causality to these factors since they 
work through various indirect mechanisms; nonetheless, they do increase systemic 
stress which in turn could lead to cancer development.   
Much about our modern lifestyle is mismatched with how we evolved to 
live and thrive. These mismatches promote systemic stress which in turn promotes 
genetic instability and cellular heterogeneity. Cellular heterogeneity may in turn 
promote the development of cancerous cells. Therefore, by understanding the 
evolutionary principals underlying cellular evolution and how mismatches promote 
this, we may be able to find solutions to prevent and reverse these changes. Current 
cancer research is directed towards the development of treatments for cancer using 
reductionist methods to target specific mutations in cancer cells. However, these 
treatments commonly fail (9-10). This is because tumors are heterogeneous, 
constantly evolving and routinely become resistant to therapy (3-5). Therefore, a new 
paradigm is needed in cancer research. Using an evolutionary framework to view 
how cancer develops and evolves can help guide us on how to prevent the 
development of cancer as well as develop new treatments for cancer (6-7). 
Evolutionary theory has led to the proposal of multiple different ways to treat 
cancer such as adaptive therapy (19), ecological therapy (21), phenotypic targeting 
(22), and using an evolutionary double bind (20). An evolutionary double bind occurs 
when two therapies are used in conjunction with one another, and by developing 
resistance to one therapy, a cancer cell becomes susceptible to the other (20, 72). 
While these theories remain largely untested in a clinical setting, they provide 
promising avenues for future research and clinical studies. The future of cancer 
prevention and treatment involves looking to the past and our evolutionary heritage.  
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